<p>1. Historical perspectives on psychosis risk<br>CRISTINA MEI AND PATRICK D. MCGORRY<br>2. Principles of risk, screening, and prevention in psychiatry<br>EMMA SONESON, JESUS PEREZ, AND PETER B. JONES<br>I - Risk paradigms<br>3. At-risk mental states<br>ALISON R. YUNG<br>4. Subjective disturbances in emerging psychosis: basic symptoms and self-disturbances<br>FRAUKE SCHULTZE-LUTTER, CHANTAL MICHEL, RAHEL FL €UCKIGER, AND ANASTASIA THEODORIDOU<br>5. Schizotypy, schizotypal personality, and psychosis risk<br>NEUS BARRANTES-VIDAL, ANNA RACIOPPI, AND THOMAS R. KWAPIL<br>6. Familial high risk and high-risk studies<br>LIANA ROMANIUK, STELLA W.Y. CHAN, ALIX MACDONALD, JESSIKA E. SUSSMANN, ANDREW M. MCINTOSH, HEATHER C. WHALLEY, AND STEPHEN M. LAWRIE<br>7. Psychotic-like experiences in the general population<br>COLM HEALY AND MARY CANNON<br>8. 22q11.2 deletion syndrome: a neurodevelopmental model of psychosis<br>CORRADO SANDINI, STEPHAN ELIEZ, MAUDE SCHNEIDER, AND MARCO ARMANDO<br>II - Specific areas and risk<br>9. Neuroimaging studies in people at clinical high risk for psychosis<br>GEORGE GIFFORD, ROB MCCUTCHEON, AND PHILIP MCGUIRE<br>10. Genetic studies of psychosis<br>HANNAH J. JONES, STANLEY ZAMMIT, AND JAMES T.R. WALTERS<br>11. Immune processes and risk of psychosis<br>ADAM AL-DIWANI AND THOMAS ARTHUR NICHOLLS POLLAK<br>12. Neurochemical models of psychosis risk and onset<br>DOMINIC OLIVER, GEMMA MODINOS, AND PHILIP MCGUIRE<br>13. Clinical risk factors for psychosis<br>ASWIN RATHEESH, JESSICA A. HARTMANN, AND BARNABY NELSON<br>14. Cognitive risk factors for psychosis<br>KELLY ALLOTT AND ASHLEIGH LIN<br>15. Society and risk of psychosis<br>CRAIG MORGAN, TESSA ROBERTS, BRIAN O. DONOGHUE, AND ANDREW THOMPSON<br>16. Is there sufficient evidence that cannabis use is a risk factor for psychosis?<br>MARCO COLIZZI AND SAGNIK BHATTACHARYYA<br>III - Interventions<br>17. The ethics of identifying and treating psychosis risk<br>PAOLO CORSICO AND ILINA SINGH<br>JEAN ADDINGTON, DANIJELA PISKULIC, DANIEL J. DEVOE, OLGA SANTESTEBAN-ECHARRI, AND JACQUELINE STOWKOWY<br>19. Pharmacological intervention for people at risk of psychotic disorder<br>E. BURKHARDT, K. LEOPOLD AND A. BECHDOLF<br>20. International services for assessing and treating psychosis risk<br>CHRISTY L.M. HUI, W.C. CHANG, SHERRY K.W. CHAN, EDWIN H.M. LEE, Y.N. SUEN, AND ERIC Y.H. CHEN<br>21. New paradigms to study psychosis risk: clinical staging, pluripotency, and dynamic prediction<br>RACHAEL SPOONER, JESSICA A. HARTMANN, PATRICK D. MCGORRY, AND BARNABY NELSON<br>22. Future directions in risk research<br>NIKOLAI ALBERT, LOUISE BIRKEDAL GLENTHØJ, AND MERETE NORDENTOFT</p>
